JP2005537282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005537282A5 JP2005537282A5 JP2004523305A JP2004523305A JP2005537282A5 JP 2005537282 A5 JP2005537282 A5 JP 2005537282A5 JP 2004523305 A JP2004523305 A JP 2004523305A JP 2004523305 A JP2004523305 A JP 2004523305A JP 2005537282 A5 JP2005537282 A5 JP 2005537282A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cephalotaxin
- disease
- angiogenic disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39765702P | 2002-07-22 | 2002-07-22 | |
| PCT/US2003/022926 WO2004009030A2 (en) | 2002-07-22 | 2003-07-22 | Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005537282A JP2005537282A (ja) | 2005-12-08 |
| JP2005537282A5 true JP2005537282A5 (https=) | 2006-09-07 |
Family
ID=30771096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004523305A Pending JP2005537282A (ja) | 2002-07-22 | 2003-07-22 | セファロタキシンアルカロイドによる血管新生抑制、並びにその誘導体、組成物、および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7642252B2 (https=) |
| EP (1) | EP1539179B1 (https=) |
| JP (1) | JP2005537282A (https=) |
| AU (1) | AU2003254120B2 (https=) |
| CA (1) | CA2493544A1 (https=) |
| ES (1) | ES2572145T3 (https=) |
| WO (1) | WO2004009030A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060211648A1 (en) * | 2000-04-12 | 2006-09-21 | Chemgenex Pharmaceuticals, Inc. | Naphthalimide compositions and uses thereof |
| US7135481B2 (en) * | 2000-04-12 | 2006-11-14 | Chemgenex Pharmaceuticals, Inc. | Naphthalimide compositions and uses thereof |
| US20050170015A1 (en) * | 2000-10-31 | 2005-08-04 | Brown Dennis M. | Antiproliferative colchicine compositions and uses thereof |
| WO2005087221A1 (en) * | 2004-03-15 | 2005-09-22 | Christine Allen | Biodegradable biocompatible implant and method of manufacturing same |
| WO2005117893A2 (en) * | 2004-06-04 | 2005-12-15 | Chemgenex Pharmaceuticals, Inc. | Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors |
| CA2597323A1 (en) * | 2005-02-10 | 2006-08-17 | Chemgenex Pharmaceuticals, Inc. | Medical devices |
| JP5550546B2 (ja) * | 2007-04-13 | 2014-07-16 | ケムジェネックス・ファーマシューティカルズ・インコーポレイテッド | 経口セファロタキシン剤形 |
| EP2260041A4 (en) | 2008-03-03 | 2012-04-25 | Sloan Kettering Inst Cancer | CEPHALOTAXUS ESTERS, METHOD FOR THEIR SYNTHESIS AND USES THEREOF |
| US20120283306A1 (en) * | 2011-04-27 | 2012-11-08 | Georgia Health Sciences University | Mouse model for avm |
| KR102066684B1 (ko) * | 2018-02-19 | 2020-01-15 | 가천대학교 산학협력단 | 개비자나무 추출물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 자가면역질환의 예방 또는 치료용 조성물 |
| KR102174166B1 (ko) * | 2018-12-13 | 2020-11-04 | 영남대학교 산학협력단 | 호모해링토닌을 유효성분으로 함유하는 세포노화 관련 질환 예방 또는 치료용 조성물 |
| KR102066683B1 (ko) * | 2019-09-16 | 2020-01-15 | 가천대학교 산학협력단 | 개비자나무 추출물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 자가면역질환의 예방 또는 치료용 조성물 |
| KR102209386B1 (ko) * | 2020-01-09 | 2021-02-01 | 영남대학교 산학협력단 | 호모해링토닌을 유효성분으로 함유하는 대사질환 예방 또는 치료용 약학조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3793454A (en) * | 1971-11-12 | 1974-02-19 | Us Agriculture | Harringtonine and isopharringtonine for treating l1210 or p388 leukemic tumors in mice |
| US4152214A (en) * | 1977-10-07 | 1979-05-01 | The United States Of America As Represented By The Secretary Of Agriculture | Production of homodeoxyharringtonine and other cephalotaxine esters by tissue culture |
| JPS5835146A (ja) * | 1981-08-28 | 1983-03-01 | Isukura Sangyo Kk | ２−ケト−６−メチル−５−ヘプテン酸エチルエステルの製造方法 |
| US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| ATE355379T1 (de) | 1994-04-26 | 2006-03-15 | Childrens Medical Center | Angiostatin und verfahren zu seiner nutzung zur vermeidung der angiogenese |
| WO1999001118A2 (en) * | 1997-07-01 | 1999-01-14 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| DE69919179T2 (de) * | 1998-09-09 | 2005-07-28 | Inflazyme Pharmaceuticals, Ltd., Richmond | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen |
| US6465424B1 (en) * | 1999-02-17 | 2002-10-15 | Bristol-Myers Squibb Company | Anti-angiogenic agent and method for inhibiting angiogenesis |
| JP2003527337A (ja) * | 1999-11-12 | 2003-09-16 | エントレメッド インコーポレイテッド | 抗血管新生スケジュールに基づく治療薬の投与方法 |
| DK1263440T3 (da) | 2000-03-15 | 2006-10-23 | Chemgenex Pharmaceuticals Inc | Cephalotaxinalkaloidkombinationspræparater og anvendelser deraf |
| EP1274458B1 (en) * | 2000-04-12 | 2005-09-28 | ChemGenex Pharmaceuticals, Inc. | Compositions containing a naphthalmide and an antiproliferative agent |
| WO2002003904A1 (en) | 2000-06-21 | 2002-01-17 | Shigeo Takizawa | Lift device capable of performing activating motion |
| AU7940500A (en) * | 2000-10-17 | 2002-04-29 | Oncopharm Corp | New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| ATE369894T1 (de) * | 2000-11-22 | 2007-09-15 | Novartis Pharma Gmbh | Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität |
| CN100396286C (zh) * | 2002-12-30 | 2008-06-25 | 北京大学第一医院 | 高三尖杉酯碱和三尖杉酯碱在制备抑制血管生成药物中的应用 |
-
2003
- 2003-07-22 US US10/625,866 patent/US7642252B2/en not_active Expired - Fee Related
- 2003-07-22 AU AU2003254120A patent/AU2003254120B2/en not_active Ceased
- 2003-07-22 EP EP03765931.5A patent/EP1539179B1/en not_active Expired - Lifetime
- 2003-07-22 CA CA002493544A patent/CA2493544A1/en not_active Abandoned
- 2003-07-22 WO PCT/US2003/022926 patent/WO2004009030A2/en not_active Ceased
- 2003-07-22 JP JP2004523305A patent/JP2005537282A/ja active Pending
- 2003-07-22 ES ES03765931T patent/ES2572145T3/es not_active Expired - Lifetime
-
2009
- 2009-07-07 US US12/498,815 patent/US20090270368A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005537282A5 (https=) | ||
| ES2337547T3 (es) | Composiciones de liberacion controlada que contienen nimesulida. | |
| CN111035639B (zh) | 喹啉衍生物用于治疗软组织肉瘤的方法和用途以及用于治疗软组织肉瘤的药物组合物 | |
| US6503953B2 (en) | Methods for treating atopic disorders | |
| WO2021231792A1 (en) | Pharmaceutical formulations and uses thereof | |
| AU2001282988A1 (en) | Methods for Treating Atopic Disorders | |
| IL189587A (en) | Solid dispersion, a pharmaceutical composition comprising the solid dispersion and process of preparing the solid dispersion | |
| CA2432126A1 (en) | Complex of modafinil and cyclodextrin | |
| JP2004532863A5 (https=) | ||
| JP2005506987A5 (https=) | ||
| JP2005523263A5 (https=) | ||
| JP2004505036A5 (https=) | ||
| JP2009541409A5 (https=) | ||
| CN105560267A (zh) | 白术多糖在制备化疗药物引起的肠黏膜炎及肠道菌群失调中的应用 | |
| JP2009517411A5 (https=) | ||
| TW200946142A (en) | Tablet | |
| JP2009518415A5 (https=) | ||
| CN116617249B (zh) | 铁皮石斛茎/叶多糖的应用 | |
| JP2008533022A5 (https=) | ||
| JP5805891B2 (ja) | ５−ヒドロキシ−１ｈ−イミダゾール−４−カルボキサミドを含有する錠剤 | |
| CN104000790A (zh) | 拉西地平分散片及其制备方法 | |
| CN103893226A (zh) | 肉豆蔻提取物的应用 | |
| JP2002535286A5 (https=) | ||
| CN103099803B (zh) | 一种增溶与同步溶出银杏内酯的方法 | |
| CN103933195A (zh) | 一种中药组合物及其在制备防治肝疾病药物中的应用 |